When Coretta received a diagnosis of stage 4 non-small cell lung cancer (NSCLC), she was shocked. Thanks to her oncologists, they established a care plan together. Having her treatment plan underway ...

analyzed global trends in four main lung cancer subtypes: adenocarcinoma, squamous cell carcinoma, small-cell carcinoma and large-cell carcinoma. They found that adenocarcinoma has been the most ...

Here are a few strategies you can try. Receiving a diagnosis of non-small cell lung cancer (NSCLC) is life changing. It directly affects the lives of people who love you and, as a result ...

Patients with extensive-stage small cell lung cancer (ES-SCLC) saw significant survival benefits when treated with either PD-1 or PD-L1 inhibitors combined with chemotherapy, according to a new ...

KRAS is the most common mutation in non-small cell lung cancer patients, making up about 25% of all lung cancers. The KRAS gene serves as a signaling pathway for cell growth, and when there is a ...

Small-cell lung cancer (SCLC) is an aggressive form of lung cancer that displays rapid proliferation and early metastatic potential. It accounts for approximately 15% of lung cancers and is strongly ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

lung NETs - these are typical carcinoid and atypical carcinoid lung NECs - these are small cell and large cell lung NEC A specialist doctor (pathologist) looks at the cancer cells under a microscope.

Lung neuroendocrine cancers are lung cancers that develop in the neuroendocrine cells of the lung. Your healthcare team might also call them lung neuroendocrine neoplasms (lung NENs). But this means ...

There is a commercial access agreement for pembrolizumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact keiron.hughes@msd.com ...